Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Strategies for the Use of Dupilumab in Eosinophilic Esophagitis — Bryan G. Sauer (2023) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Strategies for the Use of Dupilumab in Eosinophilic Esophagitis
Shared by
Peter J Barnes
Imperial College London
Strategies for the Use of Dupilumab in Eosinophilic Esophagitis
Article
2023
en
Authors
BS
Bryan G. Sauer
Peter J Barnes
Imperial College London
EM
Emily C. McGowan
Abstract
1 min read
Sauer, Bryan G. MD, MSc, FACG; Barnes, Barrett H. MD; McGowan, Emily C. MD, PhD Author Information
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2003
Changes of Methodology in Clinical Trials of Sepsis Over Time
Jürgen Graf
,
Gordon S. Doig
,
Deborah J. Cook
,
Jean Louis Vincent
,
William J. Sibbald
Letter
2007
A 2-Year, Open-Label Pilot Study of Adjunctive Chromium in Patients With Treatment-Resistant Rapid-Cycling Bipolar Disorder
Benedikt L. Amann
,
Roland Mergl
,
Eduard Vieta
,
Christoph Born
,
Igor Hermisson
,
Florian Seemueller
,
Sandra Dittmann
,
Heinz Grunze
Article
1990
Recent advances in the etiology and epidemiology of head and neck cancer
Peter Boyle
,
Tongzhang Zheng
,
Gary J. Macfarlane
,
Rachel McGinn
,
Patrick Maisonneuve
,
Carlo La Vecchia
,
C Scully
Letter
2009
Personalized Genetic Prediction: Too Limited, Too Expensive, or Too Soon?
John P A Ioannidis
Letter
2009
Response to Shen J, Kobak K, Zhao Y, et al. Use of Remote Centralized Raters Via Live 2-Way Video in a Multicenter Clinical Trial for Schizophrenia. (J Clin Psychopharmacol. 2008;28:691-693)
Heinz Grunze
,
Cyril Höschl
,
Stuart Montgomery
,
Norman Sartorius
,
Eduard Vieta
Discussion(0)
No comments yet. Be the first to comment.